Lisa Du

How Japanese drugmaker Takeda’s $62b Shire deal reshapes pharma world

It’s part of a larger shift in the industry as drugmakers scramble to consolidate, seeking to bulk up to survive the increasing pressure from stricter regulations on drug prices and looming patent expirations.


Japan outpaces China in overseas M&As clocking record $191b worth deals in 2018

Japanese companies announced more than 1,000 offshore acquisitions totaling a record $191 billion last year, led by Takeda Pharmaceutical Co.’s blockbuster takeover of Shire Plc.


Japan’s PE Unison Capital exploring sale options for Ayumi Pharma

Unison is working with JPMorgan to gauge buyer interest in the drugmaker, which may be valued at around $1 billion.


Praxair said to near $6b Europe asset sale to Taiyo Nippon

The asset sale is part of a plan to gain approval for a tie up with Germany’s Linde AG.


Xerox ends $6.1b Fujifilm deal in triumph for activist investor Icahn

The settlement marks the end of a tumultuous fight between Xerox and Icahn over a transaction that would cede control of the once-iconic American innovator synonymous with office copy machines to a Japanese company.


Luxury beauty firms delve into tech M&A to attract online shoppers, younger customers

The target is to help shoppers replicate online the experience of trying on cosmetics in a store, and use data from smart devices to create personalized makeup for customers.


Japan’s used luxury items startup Sou makes strong debut on Tokyo exchange

The company, named after the Chinese character for “thought,” has a network of 57 stores across Japan.


Asahi to sell its stake in China’s Tsingtao Brewery for $941m

Asahi is selling its stake as it expands in Europe, where it acquired about $11 billion in beer brands from Anheuser-Busch and SAB Miller.


Uniqlo, 7-Eleven owners bet overseas to counter an aging Japan

Stagnant spending and soft wage growth in Japan are forcing two of Asia’s biggest retailers to court overseas consumers to drive long-term growth.